Paladin News
Most Popular Paladin Story
Paladin acquires early-stage biotech, vax platform
Paladin Labs has completed its acquisition of ViRexx Medical Corp for $1.25 million. Former ViRexx shareholders could receive up to $2.5 million if certain conditions are met within the next week, Read more...
Latest Headlines
- December 23, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
